Stocksigma LogoStocksigma Logo

GlaxoSmithKline Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26

■ Revenue: 1,18,357 (+20.8% YoY | +26.1% QoQ) ■ EBITDA: 40,207 (+19.8% YoY | +36.1% QoQ) ■ EBITDA Margin (%): 34.0 (-29 bps YoY | +248 bps QoQ) ■ PAT

GlaxoSmithKline Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26

GlaxoSmithKline Pharmaceuticals Ltd · Outcome · 04 Nov 2026, 12:19 am

GlaxoSmithKline Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 1,18,357 (+20.8% YoY | +26.1% QoQ) ■ EBITDA: 40,207 (+19.8% YoY | +36.1% QoQ) ■ EBITDA Margin (%): 34.0 (-29 bps YoY | +248 bps QoQ) ■ PAT: 33,588 (+30.4% YoY | +41.6% QoQ) ■ EPS (INR): 19.8 (+31.6% YoY | +41.6% QoQ)

Original exchange filing (PDF)

More announcements from GlaxoSmithKline Pharmaceuticals Ltd

All GlaxoSmithKline Pharmaceuticals Ltd announcements